Reports of atypical shoulder pain and dysfunction following inactivated influenza vaccine, Vaccine Adverse Event Reporting System (VAERS), 2010-2017
- PMID: 31784231
- DOI: 10.1016/j.vaccine.2019.11.023
Reports of atypical shoulder pain and dysfunction following inactivated influenza vaccine, Vaccine Adverse Event Reporting System (VAERS), 2010-2017
Abstract
Background: Vaccines administered into or too close to underlying joint structures have the potential to cause shoulder injuries. Limited data exist on the epidemiology of such events.
Objective: To describe case reports of atypical shoulder pain and dysfunction following injection of inactivated influenza vaccine (IIV).
Methods: We searched the Vaccine Adverse Event Reporting System (VAERS) database from July 2010 to June 2017 for reports of atypical shoulder pain and dysfunction following IIV. When identifying reports, we made no assumptions about true incident injury or causality with respect to vaccination. Pain had to begin <48 h after vaccination and signs and symptoms had to continue for >7 days to differentiate from self-limited local reactions. We conducted descriptive analysis.
Results: We identified 1220 reports that met our case definition (2.0% of all IIV reports, range 1.5%-2.5% across influenza seasons). Median age was 52 years (range 16-94) and most patients (82.6%) were female. Shoulder pain (44.1%), injected limb mobility decreased (40.8%), joint range of motion decreased (21.2%), rotator cuff syndrome (9.2%), and bursitis (9.0%) were frequently reported. In 86.6% of reports, signs and symptoms had not resolved by the time of report submission. In reports that included descriptions suggesting contributing factors (n = 266), vaccination given "too high" on the arm was cited in 81.2%. Nearly half (n = 605, 49.6%) of reports described a healthcare provider evaluation. Treatments included non-narcotic analgesics, physical therapy, and corticosteroid injection. Vaccinations were most commonly administered in a pharmacy or retail store (41.0%) or doctor's office or hospital (31.6%).
Conclusions: Reports of atypical shoulder pain and dysfunction following IIV were uncommon, considering the amount of IIV use, and stable across influenza seasons. While specific etiology of cases is unknown, improperly administered vaccine, which is preventable, might be a factor. Prevention strategies include education, training, and adherence to best practices for vaccine administration.
Keywords: Shoulder injury related to vaccine administration (SIRVA); Shoulder pain; Vaccination; Vaccine Adverse Event Reporting System (VAERS); Vaccine administration; Vaccine safety.
Published by Elsevier Ltd.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Safety of co-administration of mRNA COVID-19 and seasonal inactivated influenza vaccines in the vaccine adverse event reporting system (VAERS) during July 1, 2021-June 30, 2022.Vaccine. 2023 Mar 10;41(11):1859-1863. doi: 10.1016/j.vaccine.2022.12.069. Epub 2023 Jan 9. Vaccine. 2023. PMID: 36669964 Free PMC article. Review.
-
Post-licensure surveillance of trivalent adjuvanted influenza vaccine (aIIV3; Fluad), Vaccine Adverse Event Reporting System (VAERS), United States, July 2016-June 2018.Vaccine. 2019 Mar 7;37(11):1516-1520. doi: 10.1016/j.vaccine.2019.01.052. Epub 2019 Feb 7. Vaccine. 2019. PMID: 30739795
-
Surveillance of Adverse Events After Seasonal Influenza Vaccination in Pregnant Women and Their Infants in the Vaccine Adverse Event Reporting System, July 2010-May 2016.Drug Saf. 2017 Feb;40(2):145-152. doi: 10.1007/s40264-016-0482-1. Drug Saf. 2017. PMID: 27988883 Free PMC article.
-
Post-licensure surveillance of quadrivalent inactivated influenza (IIV4) vaccine in the United States, Vaccine Adverse Event Reporting System (VAERS), July 1, 2013-May 31, 2015.Vaccine. 2016 May 11;34(22):2507-12. doi: 10.1016/j.vaccine.2016.03.048. Epub 2016 Mar 23. Vaccine. 2016. PMID: 27015735 Free PMC article. Review.
-
Adverse events after Fluzone ® Intradermal vaccine reported to the Vaccine Adverse Event Reporting System (VAERS), 2011-2013.Vaccine. 2013 Oct 9;31(43):4984-7. doi: 10.1016/j.vaccine.2013.08.001. Epub 2013 Aug 29. Vaccine. 2013. PMID: 23994022 Free PMC article.
Cited by
-
Adhesive capsulitis following COVID-19 vaccination: a case report and review of literature.J Surg Case Rep. 2023 Nov 12;2023(11):rjad611. doi: 10.1093/jscr/rjad611. eCollection 2023 Nov. J Surg Case Rep. 2023. PMID: 37965532 Free PMC article.
-
Arthroscopic debridement for acute hemorrhagic subacromial bursitis following COVID-19 vaccine administration: A case report.Shoulder Elbow. 2023 Oct;15(5):527-533. doi: 10.1177/17585732221090821. Epub 2022 Mar 31. Shoulder Elbow. 2023. PMID: 37811386
-
Adhesive Capsulitis Secondary to COVID-19 Vaccination - A Case Series.Malays Orthop J. 2023 Jul;17(2):43-48. doi: 10.5704/MOJ.2307.007. Malays Orthop J. 2023. PMID: 37583521 Free PMC article.
-
Shoulder Injury Related to Vaccine Administration (SIRVA) Is Real: A Case Report.Vaccines (Basel). 2023 Jun 27;11(7):1164. doi: 10.3390/vaccines11071164. Vaccines (Basel). 2023. PMID: 37514980 Free PMC article.
-
Does COVID-19 vaccine exacerbate rotator cuff symptoms? A prospective study.BMC Musculoskelet Disord. 2023 Jul 4;24(1):551. doi: 10.1186/s12891-023-06660-y. BMC Musculoskelet Disord. 2023. PMID: 37403025 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous